Duke Cancer Institute (Adults and Pediatrics) — Durham, North Carolina

Duke Cancer Institute (Adults and Pediatrics) is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Cancer Institute (Adults and Pediatrics) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.

Sponsors: Pierre Fabre Medicament.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Institute (Adults and Pediatrics)?

Duke Cancer Institute (Adults and Pediatrics) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Institute (Adults and Pediatrics) conducted?

Duke Cancer Institute (Adults and Pediatrics) has 1 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.

Is Duke Cancer Institute (Adults and Pediatrics) accredited by Crixeo Health?

Duke Cancer Institute (Adults and Pediatrics) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Institute (Adults and Pediatrics)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.